Items tagged with Access
Parliamentarians and civil society align on key issues around TB in Migration (post)
On 28 September 2022, the Global TB Caucus held its third Platform of Experts meeting on the theme of TB in Migration. Growing migration is an overall global trend, but the numbers have spiked in Europe due to the war in Ukraine. Across the board, consistent points of concern for migrants are access to healthcare, follow-through on treatment, and the double stigma they face: as migrants, and as people who may be more vulnerable to TB.
Target COVID-19 catch-up interventions for TB to vulnerable groups, advise scientists (post)
Vulnerable populations in 45 high-burden countries worldwide must be prioritised in efforts to reduce the impact of the COVID-19 pandemic on tuberculosis (TB) care, according to new research published in BMC Medicine.
Shorter regimen for resistant TB could save $740 million a year (post)
17 December 2022: An analysis yesterday by researchers with the TB Alliance, Stop TB Partnership, World Health Organization (WHO), and other groups estimates that the recently approved BPaLM/BPaL treatment regimen for drug-resistant tuberculosis (DR-TB) could save governments up to $740 million a year, enough to supply more than 400,000 people with almost a year's worth of DR-TB treatment.
Transformative solutions for equitable access to TB services for persons with disabilities (post)
On the 3rd of December every year, the world observes the International Day of Persons with Disabilities. This day aims to promote better understanding of issues faced by people with disabilities, and to mobilize support for their dignity, rights and well-being. This year’s theme “Transformative solutions for inclusive development: the role of innovation in fuelling an accessible and equitable world” calls for actions to tackle challenges affecting the lives of persons with disabilities through innovation and technology solutions for inclusive development.
With daily injections and two years of costly treatment, TB survivors look for a ray of light (post)
The 1/4/6x24 (one, four, six by 2024) campaign calls for TB patients to have access to evidence-based, long-awaited, shorter, less toxic treatment. But without mass availability of drugs, can India afford to adopt the protocol, ask experts.
Final hearing in TB drug patent case ends, verdict likely in a month (post)
New Delhi: The Indian Patent Office had held its final hearing on a challenge filed by two tuberculosis survivors to prevent the Indian arm of drugmaker Johnson & Johnson from extending its patent on bedaquiline, used against drug-resistant TB, beyond the primary patent’s expiry in July.
365 days of war: Ukrainian HIV/TB response stands strong! (post)
On February 24, 2022, at 5.00 a.m., Russia started its large-scale military offensive on the territory of Ukraine. The shortest month of a year turned out to be the longest bloodshed of a year for Ukrainians and the entire civilized world.
RESIST-TB webinar: DR-TB drugs under the microscope (post)
RESIST-TB will host a webinar on 9 March 2023, Drug-resistant TB (DR-TB) drugs under the microscope. The speakers will present on pricing elements and intellectual property/licensing for DR-TB medicines.
Global Fund, USAID and Stop TB Partnership's new collaboration with Molbio Diagnostics will increase access to rapid molecular tests for TB (post)
GENEVA/WASHINGTON, 09 March 2023 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the United States Agency for International Development (USAID) and the Stop TB Partnership announced a new collaboration today with Molbio Diagnostics that significantly reduces the price of the Truenat® MTB and MTB Plus tests, including a supply of MTB-RIF Dx tests for subsequent testing for rifampicin resistance, and ensures timely service and maintenance of diagnostic instruments. This collaboration will expand equitable access to quality rapid testing to underserved populations across all countries supported by the Global Fund, USAID and the Stop TB Partnership.
Feasible and effective new community-based diagnostic technique for TB (post)
Results from a community-based trial of a new package for diagnosing TB emphasise the importance of moving towards an active case finding approach for the disease.
Page 48 of 81 · Total posts: 0
←First 47 48 49 Last→